CME Group has introduced futures contracts based on the S&P UBS USD Liquid Leveraged Loan Index, starting trading on September 14, 2026. This product offers institutions a capital-efficient, centrally cleared tool to manage leveraged loan exposures beyond traditional investment grade and high-yield markets. The futures provide cross-margining benefits with other CME products, enhancing balance sheet capacity and market participation. This launch marks a significant development in the U.S. leveraged loan market, expanding tradable loan index options for investors.
The CME Group's launch of the Liquid Leveraged Loan Index Futures provides a new tool in credit markets. For readers following financial stocks, here is Pluang's market snapshot as of Sep 16, 2026 01:02 WIB: Among 74 priced Financials-sector US stocks, only 13 rose while 59 fell. Notably, Nasdaq Inc (NDAQ) traded at USD 89.68 with a 1-day change of -2.06%, Morgan Stanley (MS) was at USD 202.50 down -1.98%, and Moody's Corporation (MCO) stood at USD 468.83 with a -1.93% change.
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. This legal action could impact shareholders of the company, highlighting possible mismanagement or misconduct at the le...
